Vasculitis: Large, Medium, Small Vessel (MRCP Part 1)
- Crack Medicine

- 2 hours ago
- 4 min read
TL;DR
Vasculitis is a high-yield, classification-driven topic in MRCP Part 1, where questions test your ability to distinguish large, medium, and small vessel syndromes using clinical patterns and antibody profiles. Mastering ANCA associations, organ involvement, and classic exam traps is essential. This guide provides a structured framework, mini-case practice, and a focused revision checklist.
Why this matters
Vasculitis questions in MRCP Part 1 are not about memorising obscure pathology slides. They test structured reasoning:
Can you classify by vessel size?
Can you map antibodies to diseases?
Can you recognise organ-system patterns?
Can you avoid common mimics?
The exam follows the Chapel Hill Consensus classification system (2012 update) (Watts et al., Arthritis & Rheumatism, 2013: https://pubmed.ncbi.nlm.nih.gov/24174329/). Understanding this framework simplifies the entire topic.
If you are building foundations, review the MRCP Part 1 overview first, then return here to consolidate vasculitis.
Classification Framework (Core Table You Must Know)
Vessel Size | Key Conditions | Classic Clue | Antibody |
Large | Giant cell arteritis (GCA), Takayasu arteritis | Limb claudication, pulseless disease | None specific |
Medium | Polyarteritis nodosa (PAN), Kawasaki disease | Renal infarcts (no GN), coronary aneurysm | HBV (PAN association) |
Small (ANCA-associated) | GPA, MPA, EGPA | ENT + lung + kidney | PR3 or MPO |
Small (immune complex) | IgA vasculitis, cryoglobulinaemia, anti-GBM | Palpable purpura, GN | IgA, cryoglobulins, anti-GBM |
This classification answers a significant proportion of exam stems.
The 5 Most Tested Subtopics
1. Giant Cell Arteritis (GCA)
Guidelines from the British Society for Rheumatology emphasise urgent steroid treatment in suspected cases (https://academic.oup.com/rheumatology/article/59/3/e1/5687641).
High-yield associations:
Age >50
New temporal headache
Jaw claudication
Visual disturbance
Association with polymyalgia rheumatica
Exam pearl:Do not delay steroids for biopsy if vision is threatened.
2. Takayasu Arteritis
Young woman
Reduced or absent upper limb pulses
BP discrepancy
Subclavian stenosis
Classic phrase: “Pulseless disease.”EULAR overview: https://ard.bmj.com/content/78/1/19
3. Polyarteritis Nodosa (PAN)
Key features:
Medium vessel necrotising vasculitis
Renal infarction
Mononeuritis multiplex
Livedo reticularis
Association with hepatitis B
Crucial exam point: PAN spares glomeruli.Review: https://www.ncbi.nlm.nih.gov/books/NBK482157/
4. ANCA-Associated Vasculitis (AAV)
Extensively tested in MRCP.
EULAR recommendations (2022): https://ard.bmj.com/content/81/4/570
Granulomatosis with Polyangiitis (GPA)
ENT disease (chronic sinusitis, saddle nose)
Cavitating lung nodules
Rapidly progressive GN
PR3-ANCA (c-ANCA)
Microscopic Polyangiitis (MPA)
GN + pulmonary haemorrhage
No granulomas
MPO-ANCA (p-ANCA)
Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Asthma
Eosinophilia
Neuropathy
Often MPO-ANCA
Asthma + eosinophilia = EGPA until proven otherwise.
5. Immune Complex Small Vessel Vasculitis
IgA Vasculitis
Palpable purpura
Abdominal pain
Arthralgia
IgA nephropathy
NICE CKS summary: https://cks.nice.org.uk/topics/henoch-schonlein-purpura/
Cryoglobulinaemia
Associated with hepatitis C
Purpura + neuropathy + GN
Low complement levels
Review article: https://pubmed.ncbi.nlm.nih.gov/31506186/
Anti-GBM Disease (Goodpasture’s)
Pulmonary haemorrhage
Rapidly progressive GN
Anti-GBM antibodies

10 High-Yield Exam Points
PAN does not cause glomerulonephritis.
GPA = granulomas + PR3-ANCA.
MPA = GN + pulmonary haemorrhage + MPO-ANCA.
EGPA requires asthma history.
GCA only in >50 years.
Takayasu in young women.
Cryoglobulinaemia → low complement.
Anti-GBM = lung + kidney only.
Endocarditis can produce ANCA positivity.
Cholesterol emboli mimic vasculitis but show eosinophilia.
Reinforce these patterns using the Free MRCP MCQs section.
Mini-Case (MRCP Style)
A 61-year-old man presents with sinusitis, haemoptysis and rising creatinine. Urinalysis reveals red cell casts. CXR shows multiple cavitating nodules.
Most likely diagnosis?
Answer: Granulomatosis with polyangiitis.
Explanation: ENT involvement + lung cavitation + rapidly progressive GN = classic GPA triad.
If asthma and eosinophilia were present → think EGPA.If no ENT involvement → consider MPA or anti-GBM.
Practise under timed conditions with Start a mock test.
Five Common Exam Traps
Confusing PAN with MPA
Assuming all small vessel vasculitis are ANCA positive
Ignoring age clues in GCA
Missing hepatitis associations
Over-relying on antibody tests instead of clinical pattern
Practical Study Checklist
Step 1 – Memorise the Classification Table
Rewrite it from memory daily for 7 days.
Step 2 – Antibody Mapping
Create a one-page sheet:
PR3 → GPA
MPO → MPA/EGPA
Anti-GBM → Goodpasture’s
Step 3 – Organ Triads
Practise recognising:
ENT + lung + kidney
Asthma + eosinophilia
Purpura + abdominal pain
Step 4 – Timed Practice
Use the Free MRCP MCQs bank regularly.
Step 5 – Review Errors
Categorise mistakes:
Misclassification
Antibody confusion
Missed systemic clue
FAQs
How is vasculitis classified in MRCP Part 1?
By vessel size: large, medium and small. Small vessel is divided into ANCA-associated and immune complex types.
What is the difference between GPA and MPA?
GPA has granulomas and ENT involvement; MPA does not. GPA is usually PR3-ANCA positive, MPA is MPO-ANCA positive.
Does PAN cause glomerulonephritis?
No. PAN affects medium vessels and causes renal infarction but spares glomeruli.
Which vasculitis is associated with asthma?
Eosinophilic granulomatosis with polyangiitis (EGPA).
Which infections are linked to vasculitis?
Hepatitis B is linked to PAN; hepatitis C to cryoglobulinaemic vasculitis.
Ready to start?
Mastering vasculitis requires classification clarity and repeated exposure to exam-style stems. Consolidate your preparation using the MRCP Part 1 overview and reinforce knowledge with the Free MRCP MCQs and Start a mock test today.
Sources
Chapel Hill Consensus Conference Nomenclature (2012): https://pubmed.ncbi.nlm.nih.gov/24174329/
British Society for Rheumatology GCA Guidelines: https://academic.oup.com/rheumatology/article/59/3/e1/5687641
EULAR AAV Recommendations 2022: https://ard.bmj.com/content/81/4/570
NICE CKS – IgA Vasculitis: https://cks.nice.org.uk/topics/henoch-schonlein-purpura/
NCBI Bookshelf – PAN: https://www.ncbi.nlm.nih.gov/books/NBK482157/
NCBI Bookshelf – Anti-GBM Disease: https://www.ncbi.nlm.nih.gov/books/NBK459291/



Comments